DK478287A - Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden - Google Patents

Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden

Info

Publication number
DK478287A
DK478287A DK478287A DK478287A DK478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A DK 478287 A DK478287 A DK 478287A
Authority
DK
Denmark
Prior art keywords
procedure
erythropoietin
exercise
preparing
cell
Prior art date
Application number
DK478287A
Other languages
English (en)
Other versions
DK478287D0 (da
Inventor
Anton K Beck
Raymond M Withy
James R Zabrecky
Nicholas C Masiello
Original Assignee
Integrated Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integrated Genetics Inc filed Critical Integrated Genetics Inc
Publication of DK478287D0 publication Critical patent/DK478287D0/da
Publication of DK478287A publication Critical patent/DK478287A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK478287A 1986-09-15 1987-09-14 Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden DK478287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/907,369 US4954437A (en) 1986-09-15 1986-09-15 Cell encoding recombinant human erythropoietin

Publications (2)

Publication Number Publication Date
DK478287D0 DK478287D0 (da) 1987-09-14
DK478287A true DK478287A (da) 1988-03-16

Family

ID=25423973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK478287A DK478287A (da) 1986-09-15 1987-09-14 Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden

Country Status (6)

Country Link
US (1) US4954437A (da)
EP (1) EP0267678A1 (da)
JP (1) JPS63185396A (da)
DK (1) DK478287A (da)
FI (1) FI873897A (da)
PT (1) PT85699B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217689B1 (en) 1989-10-13 2007-05-15 Amgen Inc. Glycosylation analogs of erythropoietin
KR100221066B1 (ko) * 1989-10-13 1999-10-01 스튜어트 엘.왓트 에리트로포이에틴 유사체와 그를 포함하는 제약학적 조성물
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
EP0620849B1 (en) * 1992-01-07 2003-06-25 Elan Pharmaceuticals, Inc. Transgenic animal models for alzheimer's disease
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6153407A (en) * 1992-07-28 2000-11-28 Beth Israel Deaconess Medical Center Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
US5614184A (en) * 1992-07-28 1997-03-25 New England Deaconess Hospital Recombinant human erythropoietin mutants and therapeutic methods employing them
ZA946122B (en) * 1993-08-17 1995-03-20 Amgen Inc Erythropoietin analogs
US5459031A (en) * 1993-11-05 1995-10-17 Amgen Inc. Methods for controlling sialic acid derivatives in recombinant glycoproteins
US5919758A (en) * 1994-03-22 1999-07-06 Beth Israel Deaconess Medical Center Modified polypeptides with altered biological activity
US5888774A (en) * 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
GB9506051D0 (en) * 1995-03-24 1995-05-10 Univ Singapore Gene expression
IL118201A (en) 1995-05-11 2004-12-15 Roche Diagnostics Gmbh Preparation comprising a protein with human erythropoietin activity which is free of serum and non-recombinant mammalian protein and process for the preparation thereof
US6717031B2 (en) 1995-06-07 2004-04-06 Kate Dora Games Method for selecting a transgenic mouse model of alzheimer's disease
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
WO1998047922A2 (en) * 1997-04-21 1998-10-29 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
US6187564B1 (en) 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
CA2298015C (en) * 1997-07-23 2015-01-27 Roche Diagnostics Gmbh Production of erythropoietin by endogenous gene activation
US6548296B1 (en) 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
KR100622203B1 (ko) 1997-07-23 2006-09-07 로셰 디아그노스틱스 게엠베하 내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
TR200000140T2 (tr) 1997-07-23 2000-05-22 Roche Diagnostics Gmbh Endojenik gen etkinliği ile insan proteini üretimi için insan hücre sıralarının belirlenmesi
PT986644E (pt) 1997-07-23 2007-01-31 Roche Diagnostics Gmbh Preparação de eritropoietina por activação genética endógena com promotores virais
DE69726571T2 (de) * 1997-09-01 2004-11-04 Aventis Pharma Deutschland Gmbh Rekombinantes humanes Erythropoietin mit vorteilhaftem Glykosylierungsmuster
JP4220125B2 (ja) * 1997-12-03 2009-02-04 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 高い比活性を有するエリスロポエチン
AR020848A1 (es) 1998-10-23 2002-05-29 Amgen Inc Metodos y composiciones para la prevencion y el tratamiento de anemia
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
PE20010288A1 (es) 1999-07-02 2001-03-07 Hoffmann La Roche Derivados de eritropoyetina
CA2423093C (en) 2000-09-25 2013-09-17 Valentis, Inc. Improved system for regulation of transgene expression
BR0116381A (pt) 2000-12-20 2004-02-25 Hoffmann La Roche Conjugado, composição farmacêutica que compreende o mesmo e sua utilização, processo para o tratamento profilático e/ou terapêutico de distúrbios, processo para a preparação de um conjugado, compostos e glicoproteìnas de eritropoetina
DE60322225D1 (en) * 2002-08-09 2008-08-28 Merck Patent Gmbh T-zellen-epitope in erythropoietin
DK1699915T3 (da) 2003-12-30 2010-09-13 Augustinus Bader Anvendelse af erythropoietin til levervævsregenerering
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
CN101062407A (zh) 2006-04-29 2007-10-31 中国科学院上海生命科学研究院 促红细胞生成素在预防或治疗视网膜损伤中的用途
JP5723528B2 (ja) 2006-08-04 2015-05-27 プロロング ファーマシューティカルズ エルエルシー 修飾されたエリスロポエチン
WO2008033375A2 (en) 2006-09-14 2008-03-20 Medgenics Ltd. Long lasting drug formulations
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
EP2089424B1 (en) * 2006-12-06 2015-07-01 JCR PHARMACEUTICALS Co., LTD. Method for production of human erythropoietin
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
DE102008002210A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur fermentativen Herstellung von Erythropoietin
KR101038532B1 (ko) * 2008-07-02 2011-06-02 학교법인 선목학원 인간 적혈구생성촉진인자(ｈＥＰＯ) 유전자를 내장하는레트로바이러스 발현벡터 및 이에 의해 형질전환된동물세포 및 가금
EP2334699B1 (en) 2008-09-23 2013-09-11 F. Hoffmann-La Roche AG Purification of erythropoietin
DE102008054716A1 (de) 2008-12-16 2010-06-17 Evonik Degussa Gmbh Inprozesskontrolle in einem Verfahren zur Herstellung von EPO
MX356669B (es) 2009-05-02 2018-06-08 Genzyme Corp Terapia genica para trastornos neurodegenerativos.
MX2012003558A (es) 2009-09-23 2012-07-03 Biogenerix Ag Procedimiento para la purificacion de eritropoyetina humana recombinante (epo), epo asi purificada y composiciones farmaceuticas que la comprenden.
JP2013532152A (ja) 2010-06-15 2013-08-15 メドジェニクス・メディカル・イスラエル・リミテッド 長期持続性の医薬製剤
CN103205478B (zh) * 2013-04-03 2014-03-05 北京四环生物制药有限公司 一种重组人促红素的工业化生产方法
WO2022159414A1 (en) 2021-01-22 2022-07-28 University Of Rochester Erythropoietin for gastroinfestinal dysfunction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4419446A (en) * 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
IL77081A (en) * 1984-12-04 1999-10-28 Genetics Inst AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
DE3789678T2 (de) * 1986-02-27 1994-08-11 Snow Brand Milk Prod Co Ltd Herstellung von erythropoietinproduzierenden Zellen und Verfahren zur Herstellung von Erythropoietin mit Verwendung dieser Zellen.

Also Published As

Publication number Publication date
AU604051B2 (en) 1990-12-06
PT85699A (en) 1987-10-01
FI873897A (fi) 1988-03-16
JPS63185396A (ja) 1988-07-30
FI873897A0 (fi) 1987-09-09
US4954437A (en) 1990-09-04
EP0267678A1 (en) 1988-05-18
PT85699B (pt) 1990-08-31
DK478287D0 (da) 1987-09-14
AU7842987A (en) 1989-03-16

Similar Documents

Publication Publication Date Title
DK478287D0 (da) Erythropoietin, fremgangsmaade til fremstilling deraf og celle til brug ved udoevelse af fremgangsmaaden
DK437883D0 (da) Vandige mikroemulsioner, deres fremstilling og anvendelse
DK46181A (da) Fremgangsmaade til fremsilling af pyranoner og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DK542180A (da) Polykationske polymere deres fremstilling og anvendelse
DK160768C (da) Fremgangsmaade til fremstilling af epoxidpolyaddukter og haerdemiddel til brug ved udfoerelse af fremgangsmaaden
DK512286D0 (da) Fremgangsmaade til fremstilling af peptider og middel til brug ved fremgangsmaaden
DK521989D0 (da) Fremgangsmaade til dyrkning af celler og materialer til brug derved
DK163517C (da) Fremgangsmaade til fremstilling af 4'-epidaunorubicin og 3',4'-diepidaunorubicin
DK165922C (da) 1,2,3,6-tetrahydro-5-nitro-pyrimidinderivater, fremgangsmaade til deres fremstilling og deres anvendelse til bekaempelse af skadelige organismer
DK310179A (da) Fremgangsmaade til dyrkning af svampe og apparat til brug ved udoevelse af fremgangsmaaden
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
DK76890A (da) Cyclopropanderivater til brug ved fremstilling af cyclopropansyrederivater med dihalogenvinylkaede og med cis-struktur samt fremgangsmaade til fremstilling af cyclopropanderivaterne
DK266387D0 (da) Fremgangsmaade til fremstilling af pindeunderstoettede produkter, isaer spiseis, form til brug ved udoevelse af fremgangsmaaden og pindeunderstoettede produkter opnaaet ved udoevelse af fremgangsmaaden
NO820213L (no) Kjemiske forbindelser, deres fremstilling og deres anvendelse i legemidler
DK228386D0 (da) Praeparat og fremgangsmaade til paavisning af urease og anordning til brug ved fremgangsmaaden
DK145485D0 (da) Fremgangsmaade til fremstilling af pyrrolidon-derivater og mellemprodukter til brug ved udoevelse af fremgangsmaaden
DK306184D0 (da) Guaninforbindelse, fremgangsmaade til fremstilling deraf og mellemprodukt til brug ved udoevelse af fremgangsmaaden
DK467780A (da) Fremgangsmaade til fremstilling af 24,24-difluor25-hydrochlecalciferol og mellemprodukter til brug ved fremgangsmaaden
NO860475L (no) Elektrokjemisk celle og fremgangsmaate for fremstilling derav.
NO864201L (no) Hoeyeenergimaterialer og fremgangsmaate for deres fremstilling.
DK157935C (da) Acetoacetylaminophenyl-disazo-diphenylpigmenter, deres fremstilling og anvendelse
DK382286D0 (da) Elektrokemisk celle og fremgangsmaade til fremstilling af samme
DK36479A (da) 2,6-dinitrobenzenaminer deres fremstilling og anvendelse
DK492785D0 (da) Fremgangsmaade til fremstilling af milbemycinderivater og forbindelser til anvendelse ved fremgangsmaaden
DK154652C (da) L-aspartyl-d-aminosyre-dipeptidamider og d-amino-syreamider til brug ved deres fremstilling

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment